Naser Aslanabadi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Optical Coherence Tomography

Patients Undergoing

Top Venues

Pharmacology research & perspectives

Journal of cardiovascular and thoracic research

This page only lists publications with an associated author ORCID identifier.

Publications

Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, Naser Aslanabadi, Hassanali Lotfollahhi Gharakhanlu, Majid Saraei, Ahmad Ahmadzadehpournaky, Kasra Ardalan, Mohammad Reza Ardalan, Samad Ghaffari Bavil
Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial. Pharmacology research & perspectives 12 (4) (2024)
Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, Naser Aslanabadi, Hassanali Lotfollahhi Gharakhanlu, Majid Saraei, Ahmad Ahmadzadehpournaky, Kasra Ardalan, Mohammad Reza Ardalan, Samad Ghaffari Bavil
Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial. Pharmacology research & perspectives 12 (4) (2024)
Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, Naser Aslanabadi, Hassanali Lotfollahhi Gharakhanlu, Majid Saraei, Ahmad Ahmadzadehpournaky, Kasra Ardalan, Mohammad Reza Ardalan, Samad Ghaffari Bavil
Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial. Pharmacology research & perspectives 12 (4) (2024)
Naser Aslanabadi, Ahmad Separham, Leyla Valae Hiagh, Farid Karkon Shayan, Mehrnoush Toufan, Samad Ghaffari, Elgar Enamzadeh
Reply to: Comment on "Association of mean platelet volume with echocardiograffiric findings in patients with severe rheumatic mitral stenosis". Journal of cardiovascular and thoracic research 11 (4) (2019)